1. Home
  2. INDP vs NAAS Comparison

INDP vs NAAS Comparison

Compare INDP & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • NAAS
  • Stock Information
  • Founded
  • INDP 2000
  • NAAS 2019
  • Country
  • INDP United States
  • NAAS China
  • Employees
  • INDP N/A
  • NAAS N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • NAAS Other Specialty Stores
  • Sector
  • INDP Health Care
  • NAAS Consumer Discretionary
  • Exchange
  • INDP Nasdaq
  • NAAS Nasdaq
  • Market Cap
  • INDP 7.4M
  • NAAS 8.3M
  • IPO Year
  • INDP N/A
  • NAAS 2017
  • Fundamental
  • Price
  • INDP $0.45
  • NAAS $1.30
  • Analyst Decision
  • INDP Strong Buy
  • NAAS
  • Analyst Count
  • INDP 2
  • NAAS 0
  • Target Price
  • INDP $8.50
  • NAAS N/A
  • AVG Volume (30 Days)
  • INDP 43.0K
  • NAAS 1.3M
  • Earning Date
  • INDP 05-14-2025
  • NAAS 05-27-2025
  • Dividend Yield
  • INDP N/A
  • NAAS N/A
  • EPS Growth
  • INDP N/A
  • NAAS N/A
  • EPS
  • INDP N/A
  • NAAS N/A
  • Revenue
  • INDP N/A
  • NAAS $43,258,393.00
  • Revenue This Year
  • INDP N/A
  • NAAS $19.53
  • Revenue Next Year
  • INDP N/A
  • NAAS $151.36
  • P/E Ratio
  • INDP N/A
  • NAAS N/A
  • Revenue Growth
  • INDP N/A
  • NAAS 50.34
  • 52 Week Low
  • INDP $0.43
  • NAAS $1.23
  • 52 Week High
  • INDP $3.10
  • NAAS $76.80
  • Technical
  • Relative Strength Index (RSI)
  • INDP 44.18
  • NAAS 31.71
  • Support Level
  • INDP $0.36
  • NAAS $1.18
  • Resistance Level
  • INDP $0.48
  • NAAS $1.39
  • Average True Range (ATR)
  • INDP 0.05
  • NAAS 0.10
  • MACD
  • INDP 0.01
  • NAAS 0.07
  • Stochastic Oscillator
  • INDP 59.80
  • NAAS 41.38

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About NAAS NaaS Technology Inc.

Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.

Share on Social Networks: